AGF Management’s Bristol-Myers Squibb BMY Stock Holding History

AGF Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.3M	Sell	334,104 -178,784	-35%	-$10.3M	0.07%	170
2026 Q1	$31.1M	Sell	512,888 -60,511	-11%	-$3.53M	0.14%	130
2025 Q4	$30.9M	Sell	573,399 -9,910	-2%	-$477K	0.13%	126
2025 Q3	$26.3M	Sell	583,309 -4,431	-0.8%	-$207K	0.12%	136
2025 Q2	$27.2M	Buy	587,740 +8,021	+1%	+$394K	0.12%	135
2025 Q1	$35.4M	Sell	579,719 -27,345	-5%	-$1.59M	0.19%	123
2024 Q4	$34.3M	Buy	607,064 +45,901	+8%	+$2.56M	0.17%	126
2024 Q3	$29M	Buy	561,163 +4,830	+0.9%	+$227K	0.15%	139
2024 Q2	$23.1M	Sell	556,333 -21,187	-4%	-$948K	0.13%	140
2024 Q1	$31.3M	Sell	577,520 -17,400	-3%	-$886K	0.17%	137
2023 Q4	$30.5M	Buy	594,920 +7,904	+1%	+$415K	0.18%	132
2023 Q3	$34.1M	Sell	587,016 -14,025	-2%	-$859K	0.24%	115
2023 Q2	$38.4M	Sell	601,041 -14,583	-2%	-$978K	0.28%	105
2023 Q1	$42.7M	Sell	615,624 -7,948	-1%	-$561K	0.29%	102
2022 Q4	$44.9M	Buy	+623,572	New	+$47M	0.33%	90

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AGF Management's BMY Position: Q2 2026 in Review

AGF Management reduced its Bristol-Myers Squibb (BMY) stake by 35% in Q2 2026, selling an estimated $10.3M and leaving 334,104 shares worth $19.3M. The position accounts for 0.07% of the portfolio, ranked #170.

AGF Management first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $44.9M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

AGF Management held 334,104 shares of Bristol-Myers Squibb worth $19.3M as of Q2 2026.
AGF Management sold 178,784 Bristol-Myers Squibb shares in Q2 2026, an estimated $10.3M.
Bristol-Myers Squibb made up 0.07% of AGF Management's portfolio in Q2 2026, its #170 holding.
AGF Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
AGF Management's Bristol-Myers Squibb position peaked at $44.9M in Q4 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.